Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.
- 15 April 1993
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (8) , 3383-3387
- https://doi.org/10.1073/pnas.90.8.3383
Abstract
Stimulation of corticotropin-releasing factor (CRF) release from the hypothalamus by interleukin 2 (IL-2) was recently demonstrated. Cytokines induce nitric oxide synthase (NOS), an enzyme that converts L-arginine into L-citrulline and nitric oxide (NO). NO is believed to be responsible for the cytotoxic action of these agents. The constitutive form of NOS occurs in neurons in the central nervous system and NO appears to play a neurotransmitter role in cerebellar and hippocampal function. We explored the probability that IL-2 and synaptic transmitters might release CRF via NO. The effects of L-arginine, the substrate for NOS, and NG-monomethyl-L-arginine (NMMA), a competitive inhibitor of NOS, on IL-2-induced CRF release were studied using mediobasal hypothalami (MBHs) incubated in vitro in Krebs-Ringer bicarbonate buffer. L-Arginine did not alter basal and IL-2-induced CRF release after 30 min of incubation but significantly elevated both basal and IL-2-induced CRF release when MBHs were incubated 30 min longer, presumably because the endogenous substrate had been depleted after the initial 30-min incubation period. In 30-min incubations, both carbachol, an acetylcholineomimetic drug, and norepinephrine stimulated CRF release. There was an additive effect of incubation of the MBHs in the presence of carbachol (10(-7) M) and IL-2 (10(-13) M). On the other hand, coincubation of MBHs with norepinephrine (10(-6) M) and IL-2 (10(-13) M) did not produce any additive effect. Addition of NMMA, an inhibitor of NOS, at 1 or 3 x 10(-4) M completely suppressed IL-2-induced release of CRF as well as that caused by IL-2 plus carbachol. In contrast, the release of CRF induced by norepinephrine was not blocked by 3 x 10(-4) M NMMA. The data indicate that IL-2 can activate constitutive NOS leading to increased NO release, which activates CRF release. It appears that NO is also involved in the release of CRF induced by carbachol but not by norepinephrine.Keywords
This publication has 17 references indexed in Scilit:
- Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus.Proceedings of the National Academy of Sciences, 1992
- Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids.Endocrinology, 1992
- Nitric oxide, a novel neuronal messengerNeuron, 1992
- Interleukin‐2 Effects in the Central Nervous SystemaAnnals of the New York Academy of Sciences, 1990
- Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic systemBrain Research, 1989
- Acetylcholine and Norepinephrine Stimulate the Release of Corticotropin-Releasing Factor-41 from the Rat Hypothalamusin Vitro*Endocrinology, 1988
- Facilitation of Immunoreactive Corticotropin-Releasing Factor Secretion into the Hypophysial-Portal Circulation after Activation of Catecholaminergic Pathways or Central Norepinephrine Injection*Endocrinology, 1987
- Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitroLife Sciences, 1987
- NEUROTRANSMITTER REGULATION OF CORTICOTROPIN‐RELEASING FACTOR IN VITROAnnals of the New York Academy of Sciences, 1977